Mid-term follow-up results after implementing a new strategy for the diagnosis and management of periprosthetic joint infections

BMC Infect Dis. 2021 Aug 12;21(1):807. doi: 10.1186/s12879-021-06407-x.

Abstract

Background: Periprosthetic joint infections (PJIs) represent one of the most serious complications associated with joint replacement surgeries, a complication also of modern orthopedic surgery despite the efforts that occurred in this field. Frequently PJIs lead to prolonged morbidity, increased costs and mortality.

Methods: We are conducting a single-center observational cohort ongoing study in the Academic Emergency Hospital Sibiu, Romania, study in which sonication of the retrieved and as a rapid method of bacteria detection, molecular identification of bacteria by 16S rRNA beacon-based fluorescent in situ hybridization (bbFISH) are used.

Results: A total of 61 patients were enrolled in this study. The diagnosis of aseptic loosening was established in 30 cases (49.1%) and the diagnosis of periprosthetic joint infection was established at 31 patients (50.8%). The mean follow-up period in the subgroup of patients diagnosed with periprosthetic joint infections was 36.06 ± 12.59 months (range: 1-54). The 25-months Kaplan-Meier survival rate as the end point, as a consequence of the period of enrollment and a different follow-up period for each type of surgical procedure, was 75% after debridement and implant retention, 91.7% after one-stage exchange, 92.3% after two-stage exchange, and 100% after three-stage exchange. There were no significant differences in survival percentage.

Conclusions: Our study has good results similar to previously published data. We cannot recommend one strategy of managing prosthetic joint infections over the other. Definitely, there is a need for prospective randomized controlled trials.

Keywords: Biofilm; Mid-term follow-up results; Periprosthetic joint infection; Sonication; Surgical management.

Publication types

  • Observational Study

MeSH terms

  • Arthroplasty, Replacement, Hip*
  • Follow-Up Studies
  • Humans
  • In Situ Hybridization, Fluorescence
  • Prosthesis-Related Infections* / surgery
  • Prosthesis-Related Infections* / therapy
  • RNA, Ribosomal, 16S
  • Reoperation
  • Retrospective Studies

Substances

  • RNA, Ribosomal, 16S